<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-45">
 <label>45</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rosendaal</surname>
    <given-names>FR</given-names>
   </name>
   <name>
    <surname>Palla</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Garagiola</surname>
    <given-names>I</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis.</article-title>
  <source>
   <italic>Blood.</italic>
  </source>
  <year>2017</year>;
  <volume>130</volume>(
  <issue>15</issue>):
  <fpage>1757</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.1182/blood-2017-06-791756</pub-id>
  <?supplied-pmid 28768627?>
  <pub-id pub-id-type="pmid">28768627</pub-id>
 </mixed-citation>
 <note>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727874752" xmlns:xlink="http://www.w3.org/1999/xlink">F1000 Recommendation</ext-link>
  </p>
 </note>
</ref>
